Online Program Home
  My Program

All Times EDT

* = applied session       ! = JSM meeting theme

Activity Details

164 * ! Tue, 8/4/2020, 10:00 AM - 11:50 AM Virtual
Leveraging Real-World Data in the Drug Development Process — Topic Contributed Papers
Biopharmaceutical Section, Biometrics Section, Health Policy Statistics Section
Organizer(s): Rebecca A Hubbard, University of Pennsylvania
Chair(s): Nandita Mitra, University of Pennsylvania
10:05 AM Hybrid Controlled Trials with EHR-Derived Data for Cancer Trials: What, Why, When, and How
Brian Segal, Flatiron Health; Melissa Curtis, Flatiron Health; Meghna Samant, Flatiron Health; Katherine Tan, Flatiron Health; Shrujal Baxi, Flatiron Health; Somnath Sarkar, Flatiron, Inc.
10:25 AM Data-Adaptive Weighting of Real-World and Randomized Controls Using Propensity Scores
Joanna Harton, University of Pennsylvania; Nandita Mitra, University of Pennsylvania; Rebecca A Hubbard, University of Pennsylvania
10:45 AM Leveraging RWD and Historical Data in Design and Analysis of Clinical Trials
Samson Ghebremariam, Novartis Pharmaceuticals; Lisa Hampson, Novartis Pharmaceuticals; Bharani Bharani-Dharan, Novartis Oncology; Amy Racine-Poon, Novartis Pharma AG; Beat Neuenschwander, Novartis pharmaceuticals
11:05 AM Calibrated Survival Curve and Treatment Comparison with Imperfect Survival Outcomes from Electronic Health Records
Chuan Hong, Harvard Medical School; Liang Liang, Harvard T. H. Chan School of Public Health; Tianxi Cai, Harvard University
11:25 AM Discussant: Elizabeth Teeple, US Food and Drug Administration
11:45 AM Floor Discussion